Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Recursion Pharmaceuticals Inc (RXRX)

  • Business News
  • Nov. 05, 2025, 11:28 UTC
  • 12
  • 1 comments

Recursion Announces CEO Transition Plan to Drive Next Phase of Growth

Market reaction Comment Full text

Elanco Animal Health Incorporated (ELAN)

  • Business News
  • Nov. 05, 2025, 11:27 UTC
  • 12
  • 1 comments

Elanco Animal Health Reports Third Quarter 2025 Results

Market reaction Comment Full text

Avient Corp (AVNT)

  • Business News
  • Nov. 05, 2025, 11:15 UTC
  • 15
  • 1 comments

Avient Announces Third Quarter 2025 Results

Market reaction Comment Full text

LivaNova PLC (LIVN)

  • Business News
  • Nov. 05, 2025, 11:00 UTC
  • 10
  • 1 comments

LivaNova Reports Third-Quarter 2025 Results; Raises 2025 Guidance

Market reaction Comment Full text

Aclarion Inc (ACON)

  • Business News
  • Nov. 05, 2025, 11:00 UTC
  • 10
  • 1 comments

Aclarion Appoints Dan Isherwood as UK Commercial Director to Drive Adoption and Market Expansion

Market reaction Comment Full text

Immuron Limited (IMRN)

  • Business News
  • Nov. 05, 2025, 11:00 UTC
  • 10
  • 1 comments

Immuron IMM-529 IND approved by FDA

Market reaction Comment Full text

RadNet Inc (RDNT)

  • Business News
  • Nov. 05, 2025, 11:00 UTC
  • 12
  • 1 comments

RadNet Expands Comprehensive Remote Scanning Offering with Acquisition of Alpha RT’s Assets

Market reaction Comment Full text

Westlake Chemical Corporation (WLK)

  • Business News
  • Nov. 05, 2025, 10:52 UTC
  • 12
  • 1 comments

Westlake annuncia unofferta pubblica di acquisto in contanti

Market reaction Comment Full text

Westlake Chemical Corporation (WLK)

  • Business News
  • Nov. 05, 2025, 10:51 UTC
  • 12
  • 1 comments

Westlake lance une offre publique d’achat en numéraire

Market reaction Comment Full text

So-Young International Inc (SY)

  • Business News
  • Nov. 05, 2025, 10:30 UTC
  • 12
  • 1 comments

So-Young to Report Third Quarter 2025 Financial Results on November 17, 2025

Market reaction Comment Full text
  • Previous
  • 840
  • 841
  • 842
  • 843
  • 844
  • Next

Search

News categories

  • Technical Exchange News(10979)
  • Event(2467)
  • SEC News(194271)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(126337)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin